EquityFolio

CRL

NYSE HEALTHCARE

Charles River Laboratories

$260.72

$26.60 (+11.36%)

Live quote

52w: $144.26 – $266.00

Loading chart…
P/E Ratio
P/B Ratio3.83
EV/EBITDA
Debt/Equity
ROE-4.91%
ROIC
Revenue Growth-0.85%
Gross Margin
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.

Own CRL? Track it here.

Create a free account to add CRL to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account